Katharine A Brennan1, Fraser Putt, Penelope Truman. 1. School of Psychology, Victoria University of Wellington, P.O. Box 600, Wellington, 6140, New Zealand. katie.brennan@damascene.co.nz
Abstract
RATIONALE: Repeated nicotine exposure produces a weak and transient sensitised locomotor response in rats. Since tobacco smoke contains thousands of non-nicotine chemical constituents, these could alter the sensitised response. OBJECTIVES: This study aims to compare the magnitude, persistence and spatial distribution of locomotor sensitisation produced by repeated doses of nicotine, aqueous tobacco particulate matter (TPM) and a positive methamphetamine control. METHODS: Male Sprague-Dawley rats received five nicotine (0.0, 0.2 or 0.4 mg/kg), TPM (containing 0.2 or 0.4 mg/kg nicotine) or methamphetamine (0.5 mg/kg) injections every second day, followed by a 4-day withdrawal before the first challenge (Challenge 1, C1). The animals were re-challenged again at 15 days post C1 to test for the persistence of sensitisation (Challenge 2, C2). RESULTS: There were no major differences in sensitisation profile between nicotine and TPM. At the lowest 0.2 mg/kg nicotine/TPM dose, however, small differences emerged on select test days. CONCLUSIONS: The results indicated that the non-nicotinic agents in TPM did not greatly impact the nicotine-produced locomotor-sensitised response. These findings might suggest that the differential pharmacological properties of TPM do not have major clinical significance. Alternatively, the locomotor model might not expose effects of non-nicotinic constituents, and furthermore, might not closely relate to human tobacco dependence. Different reward-related behavioural models should also be utilised to assess potential effects of non-nicotinic constituents before a role in dependence is discounted.
RATIONALE: Repeated nicotine exposure produces a weak and transient sensitised locomotor response in rats. Since tobacco smoke contains thousands of non-nicotine chemical constituents, these could alter the sensitised response. OBJECTIVES: This study aims to compare the magnitude, persistence and spatial distribution of locomotor sensitisation produced by repeated doses of nicotine, aqueous tobacco particulate matter (TPM) and a positive methamphetamine control. METHODS: Male Sprague-Dawley rats received five nicotine (0.0, 0.2 or 0.4 mg/kg), TPM (containing 0.2 or 0.4 mg/kg nicotine) or methamphetamine (0.5 mg/kg) injections every second day, followed by a 4-day withdrawal before the first challenge (Challenge 1, C1). The animals were re-challenged again at 15 days post C1 to test for the persistence of sensitisation (Challenge 2, C2). RESULTS: There were no major differences in sensitisation profile between nicotine and TPM. At the lowest 0.2 mg/kg nicotine/TPM dose, however, small differences emerged on select test days. CONCLUSIONS: The results indicated that the non-nicotinic agents in TPM did not greatly impact the nicotine-produced locomotor-sensitised response. These findings might suggest that the differential pharmacological properties of TPM do not have major clinical significance. Alternatively, the locomotor model might not expose effects of non-nicotinic constituents, and furthermore, might not closely relate to humantobacco dependence. Different reward-related behavioural models should also be utilised to assess potential effects of non-nicotinic constituents before a role in dependence is discounted.
Authors: Jack E Henningfield; Tracy T Smith; Bethea A Kleykamp; Reginald V Fant; Eric C Donny Journal: Psychopharmacology (Berl) Date: 2016-10-21 Impact factor: 4.530
Authors: Andrew C Harris; Laura Tally; Clare E Schmidt; Peter Muelken; Irina Stepanov; Subhrakanti Saha; Rachel Isaksson Vogel; Mark G LeSage Journal: Drug Alcohol Depend Date: 2014-12-23 Impact factor: 4.492
Authors: Yael Abreu-Villaça; Cláudio C Filgueiras; Monique Correa-Santos; Cristiane C Cavina; Victor F Naiff; Thomas E Krahe; Alex C Manhães; Anderson Ribeiro-Carvalho Journal: Psychopharmacology (Berl) Date: 2014-11-18 Impact factor: 4.530
Authors: Andrew C Harris; Peter Muelken; Yayi Swain; Mary Palumbo; Vipin Jain; Maciej L Goniewicz; Irina Stepanov; Mark G LeSage Journal: Drug Alcohol Depend Date: 2019-08-01 Impact factor: 4.492
Authors: Tracy T Smith; Laura E Rupprecht; Rachel L Denlinger-Apte; Jillian J Weeks; Rachel S Panas; Eric C Donny; Alan F Sved Journal: Nicotine Tob Res Date: 2017-09-01 Impact factor: 4.244
Authors: Andrew C Harris; Peter Muelken; Aleksandra Alcheva; Irina Stepanov; Mark G LeSage Journal: Front Neurosci Date: 2022-05-25 Impact factor: 5.152
Authors: M G LeSage; M Staley; P Muelken; J R Smethells; I Stepanov; R I Vogel; P R Pentel; A C Harris Journal: Drug Alcohol Depend Date: 2016-09-01 Impact factor: 4.492
Authors: Tracy T Smith; Matthew B Schaff; Laura E Rupprecht; Rachel L Schassburger; Deanne M Buffalari; Sharon E Murphy; Alan F Sved; Eric C Donny Journal: Drug Alcohol Depend Date: 2015-07-13 Impact factor: 4.492
Authors: Matthew R Costello; Daisy D Reynaga; Celina Y Mojica; Nurulain T Zaveri; James D Belluzzi; Frances M Leslie Journal: Neuropsychopharmacology Date: 2014-02-11 Impact factor: 7.853